Abstract
Esophageal cancer is a highly lethal disease and the seventh leading cause of cancer-related death. In 2022, there were 511,000 new cases of esophageal cancer and 445,000 deaths from esophageal cancer worldwide.1 Esophageal cancer is made up of two distinct cancers arising in the same organ, with different causative factors and different genomic characteristics. Whereas esophageal squamous-cell carcinomas are more prevalent worldwide (85% of new cases of esophageal cancer), adenocarcinomas of the esophagus and esophagogastric junction (hereafter referred to as esophageal adenocarcinomas) are predominant in developed countries, comprising 75% of the new cases of esophageal cancer in the United States .
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call